DV
Dividend Vision

ZVRA — Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc. (ZVRA)

Total return is -93.7% over the past 11.3 years, 438.5 points behind SPY at 344.8%. Its deepest 1-year drawdown was 35.5%.

ZVRA is a healthcare equity stock that does not function as a traditional dividend ETF. The fund pays no distributions and carries no disclosed yield profile, making it unsuitable for income-focused investors. This holding appeals primarily to growth-oriented investors seeking exposure to the healthcare sector rather than those seeking regular dividend income.

ZVRA key facts

Asset type
Stock
Asset class
Equity
Inception date
04/16/2015
Distribution frequency
None
Last close
$11.32
Market cap
$672,224,384
Average volume
777800.0
Payment date
12/28/2020
Beta
0.923
Payout ratio
0.0
P/E ratio
12.172
Forward P/E
10.929
EPS
$0.93